DCF — UNIVERSITY OF MISSISSIPPI MEDICAL
Enterprise Value: $-640.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-640.9M
Enterprise Value
$-225.9M
PV of Cash Flows
$-415.0M
PV of Terminal Value
$-668.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.1B | $-27.3M | -3.0% | $-73.4M | $-66.7M |
| Year 2 | $1.1B | $-16.9M | -2.0% | $-64.4M | $-53.2M |
| Year 3 | $1.2B | $-5.8M | -1.0% | $-54.8M | $-41.1M |
| Year 4 | $1.2B | $-0.1M | -0.0% | $-50.5M | $-34.5M |
| Year 5 | $1.2B | $3.0M | 0.0% | $-48.9M | $-30.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-640.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.1B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.030046402078415725
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5